miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2

Biotechnology Letters

Volumn 36, Issue 9, 2014, Pages 1743-1752

  Li, Tong ^a   Yang, Jue ^a   Lv, Xiaobo ^a   Liu, Kunmei ^b   Gao, Chao ^a   Xing, Yingying ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Colorectal carcinoma; E2F2; MicroRNA; miR 155; Proliferation; Survivin

Indexed keywords

CYTOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; RNA;

CELL CYCLE; COLORECTAL CARCINOMA; E2F2; MICRORNAS; MIR-155; PROLIFERATION; SURVIVIN;

CELLS;

E2F2 PROTEIN, HUMAN; LUCIFERASE; MICRORNA; MIRN155 MICRORNA, HUMAN; TRANSCRIPTION FACTOR E2F2;

CELL CYCLE; CELL PROLIFERATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; REPORTER GENE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; E2F2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; LUCIFERASES; MICRORNAS;

EID: 84905222916     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-014-1540-3     Document Type: Article

References (32)

1. Babar IA, Cheng CJ, Booth CJ et al (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155) dependent mouse model of lymphoma. Proc Natl Acad Sci USA 109: E1695-E1704.
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Calame K (2007) microRNA-155 function in B cells. Immunity 27: 825-827.
4. Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301: 336-338.
5. Dai Y, Qiu Z, Diao Z et al (2012) MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta 33: 824-829.
6. DeGregori J (2002) The genetics of the E2F family of transcription factors shared functions and unique roles. Biochim Biophys Acta 1602: 131-150.
7. Dimova DK, Dyson NJ (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene 24: 2810-2826.
8. Faraoni I, Antonetti FR, Cardone J et al (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792: 497-505.
9. Foshay KM (2007) Small RNAs, big potential: the role of MicroRNAs in stem cell function. Curr Stem Cell Res Ther 2: 264-271.
10. Infante A, Laresgoiti U, Fernández-Rueda J et al (2008) E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle 7: 3915-3927.
11. Jha K, Shukla M, Pandey M (2012) Survivin expression and targeting in breast cancer. Surg Oncol 21: 125-131.
12. Jiang S, Zhang HW, Lu MH et al (2010) MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127.
13. Johnson DG, DeGregori J (2006) Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 6: 731-738.
14. Lagos-Quintana M, Rauhut R, Lendeckel W et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
15. Lee TAFP (2000) Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation. Oncogene 19: 2257-2268.
16. Li S, Chen T, Zhong Z et al (2012) microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep 5: 949-954.
17. Mattiske S, Suetani RJ, Neilsen PM et al (2012) The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomarkers Prev 21: 1236-1243.
18. McClellan KA, Ruzhynsky VA, Douda DN et al (2007) Unique requirement for Rb/E2F3 in neuronal migration evidence for cell cycle-independent functions. Mol Cell Biol 27: 4823-4825.
19. Meltzer PS (2005) Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
20. O'Connell RM, Kahn D, Gibson WSJ et al (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
21. Opavsky R, Tsai S-Y, Guimond M et al (2007) Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci USA 104: 15400-15405.
22. Pusapati RV, Weaks RL, Rounbehler RJ et al (2010) E2F2 suppresses Myc-induced proliferation and tumorigenesis. Mol Carcinog 49: 152-156.
23. Rogoff HA, Kowalik TF (2004) Life, death and E2F. Cell Cycle 3: 845-846.
24. Sun Y, Wang M, Lin G et al (2012) Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS ONE 7: e47003.
25. Timmers C, Sharma N, Opavsky R et al (2006) E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 27: 65-78.
26. Vigorito E, Perks KL, Abreu-Goodger C et al (2007) MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859.
27. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
28. Wenzel PL, Chong J-L, Sáenz-Robles MT et al (2011) Cell proliferation in the absence of E2F1-3. Dev Biol 351: 35-45.
29. Wong CF, Barnes LM, Dahle AL et al (2003) E2F modulates keratinocyte squamous differentiation. J Biol Chem 278: 28516-28522.
30. Xanthoulis A, Tiniakos DG (2013) E2F transcription factors and digestive system malignancies: how much do we know. World J Gastroenterol 19: 3189-3198.
31. Xie Q, Chen X, Lu F et al (2012) Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer 118: 2431-2442.
32. Zhang G, Xiao G, Tian H et al (2013) Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med 31: 1375-1380.